NikhilKhandelwalCFA

Biocon in Pharma Rally

看多
NSE:BIOCON   BIOCON LTD
Government take steps to ramp up production of Amphotericin B. A sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to patients suffering from Mucormycosis, a post #COVID19 complication. @businessline

Biocon will be in focus

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。